PharmD Capital Trading with PharmD_KS

PharmD Capital Trading with PharmD_KS

Share this post

PharmD Capital Trading with PharmD_KS
PharmD Capital Trading with PharmD_KS
Market Analysis and Trades for 2/14/25
Copy link
Facebook
Email
Notes
More

Market Analysis and Trades for 2/14/25

Now for the Real Test

PharmD_KS's avatar
PharmD_KS
Feb 13, 2025
∙ Paid
19

Share this post

PharmD Capital Trading with PharmD_KS
PharmD Capital Trading with PharmD_KS
Market Analysis and Trades for 2/14/25
Copy link
Facebook
Email
Notes
More
1
Share

If you are looking to join the Discord (now separate from the newsletter) please see here: JOIN THE DISCORD Please email help@pharmdcapital.com if there are any technical issues. Plans/levels will be posted in the Discord

The weekly post and for SPY 0.00%↑ and QQQ 0.00%↑ was split into two parts, the first without a paywall, and should be reviewed prior to this. Link to Market Analysis for The Week Ahead

Be sure you have read the Trading Doggy Style Starter Kit. I will be adding to this over time, likely first focusing on example executions. Trading Doggy Style Starter Kit.

NQ has been the driver for this move for some time. Even if one trades ES I have been encouraging members to watch NQ when making trade decisions. This was the case again today. While ES briefly swept its dip buy spot premarket, NQ respected its perfectly. It has been this way for some time.

ES traded down to 6053.5 on this test, held 64 on data this morning, triggered the LBAF of 68-73 and the cash hours low of day was 6070.25.

The markets have remained above our high time frame “pivots” for the entire week, favoring bulls, but truly the real test comes tomorrow. While ES has broken its recent downtrend line, the setup for tomorrow is one that often causes failed breakouts. We will continue to plan to buy dips until that is proven wrong, while maintaining awareness of the potential bearish scenarios. I’ll cover the area of concern tonight.

Trading Doggy Style with PharmD_KS is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber.

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2025 PharmD_KS
Market data by Intrinio
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share

Copy link
Facebook
Email
Notes
More